Masashi Azuma, Suyog Mokashi, Mohammed Abul Kashem, Brian O'Murchu, Yoshiya Toyoda, Roh Yanagida
{"title":"静脉-动脉体外膜氧合治疗一名耶和华见证会患者的心源性休克。","authors":"Masashi Azuma, Suyog Mokashi, Mohammed Abul Kashem, Brian O'Murchu, Yoshiya Toyoda, Roh Yanagida","doi":"10.1016/j.amjcard.2025.03.014","DOIUrl":null,"url":null,"abstract":"<p><p>Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) may support hemodynamics of patients experiencing cardiogenic shock refractory to medical management. We present a 62-year-old Jehovah's Witness female with a history of smoking, obstructive sleep apnea, and anemia presenting with acute myocardial infarction and ensuing cardiogenic shock that required V-A ECMO support due to persistent hemodynamic instability and hypoxemia. Meticulous care to blood saving strategies were employed contributing to the successful management of the patient. These strategies included minimizing frequency of laboratory testing, use of micro-pediatric tubes, meticulous tissue handling to minimize blood loss during decannulation and administration of supplementary agents (vitamin B12, folic acid, iron, and erythropoietin) in consideration with the ethical concerns of the patients and their family. During the patient's hospital stay, their hemoglobin decreased from 14.6 mg/dL to as low as 7.6 mg/dL 3 days after decannulation. To our knowledge, this is the third reported case of V-A ECMO support in a Jehovah's Witness patient and the first reported critical care case. In conclusion, employing a bloodless strategy and adhering to recommended practices can yield positive outcomes for patients who do not accept blood transfusions requiring V-A ECMO.</p>","PeriodicalId":7705,"journal":{"name":"American Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock in a Jehovah's Witness Patient.\",\"authors\":\"Masashi Azuma, Suyog Mokashi, Mohammed Abul Kashem, Brian O'Murchu, Yoshiya Toyoda, Roh Yanagida\",\"doi\":\"10.1016/j.amjcard.2025.03.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) may support hemodynamics of patients experiencing cardiogenic shock refractory to medical management. We present a 62-year-old Jehovah's Witness female with a history of smoking, obstructive sleep apnea, and anemia presenting with acute myocardial infarction and ensuing cardiogenic shock that required V-A ECMO support due to persistent hemodynamic instability and hypoxemia. Meticulous care to blood saving strategies were employed contributing to the successful management of the patient. These strategies included minimizing frequency of laboratory testing, use of micro-pediatric tubes, meticulous tissue handling to minimize blood loss during decannulation and administration of supplementary agents (vitamin B12, folic acid, iron, and erythropoietin) in consideration with the ethical concerns of the patients and their family. During the patient's hospital stay, their hemoglobin decreased from 14.6 mg/dL to as low as 7.6 mg/dL 3 days after decannulation. To our knowledge, this is the third reported case of V-A ECMO support in a Jehovah's Witness patient and the first reported critical care case. In conclusion, employing a bloodless strategy and adhering to recommended practices can yield positive outcomes for patients who do not accept blood transfusions requiring V-A ECMO.</p>\",\"PeriodicalId\":7705,\"journal\":{\"name\":\"American Journal of Cardiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amjcard.2025.03.014\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjcard.2025.03.014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock in a Jehovah's Witness Patient.
Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) may support hemodynamics of patients experiencing cardiogenic shock refractory to medical management. We present a 62-year-old Jehovah's Witness female with a history of smoking, obstructive sleep apnea, and anemia presenting with acute myocardial infarction and ensuing cardiogenic shock that required V-A ECMO support due to persistent hemodynamic instability and hypoxemia. Meticulous care to blood saving strategies were employed contributing to the successful management of the patient. These strategies included minimizing frequency of laboratory testing, use of micro-pediatric tubes, meticulous tissue handling to minimize blood loss during decannulation and administration of supplementary agents (vitamin B12, folic acid, iron, and erythropoietin) in consideration with the ethical concerns of the patients and their family. During the patient's hospital stay, their hemoglobin decreased from 14.6 mg/dL to as low as 7.6 mg/dL 3 days after decannulation. To our knowledge, this is the third reported case of V-A ECMO support in a Jehovah's Witness patient and the first reported critical care case. In conclusion, employing a bloodless strategy and adhering to recommended practices can yield positive outcomes for patients who do not accept blood transfusions requiring V-A ECMO.
期刊介绍:
Published 24 times a year, The American Journal of Cardiology® is an independent journal designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. AJC is an independent, scientific, peer-reviewed journal of original articles that focus on the practical, clinical approach to the diagnosis and treatment of cardiovascular disease. AJC has one of the fastest acceptance to publication times in Cardiology. Features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy. Also included are editorials, readers'' comments, and symposia.